Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine flexible dosing for sexual function in women with overactive bladder
ISRCTN40720691Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Feb 2011
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of fesoterodine in overactive bladder (OAB), sponsored by King's College Hospital. Primary endpoints: PISQ-12 item score change at week 12 and SQOL score change at week 12. Started Feb 2011; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on ISRCTN40720691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN40720691.